AAFS Position Statement on Naloxone
Source: Betty Layne DesPortes, JD, MS, AAFS President On August 7, 2017, after reviewing input from the membership and convening by conference call to discuss the matter, the AAFS Board of Directors voted to adopt the position statement on access to naloxone at the worksite proposed by the Synthetic Opioid Ad Hoc Committee. The Board […]